Zvi Shmuel Ben
Director · Protalix BioTherapeutics, Inc.
Individual
- 2025
- Sep 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Zvi Shmuel Ben files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amos Bar-Shalev - $314 in PLX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Zvi Shmuel Ben?
Zvi Shmuel Ben is a corporate insider, tracked as Director of Protalix BioTherapeutics, Inc. (PLX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Zvi Shmuel Ben submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
